Meryl A. Waldman, M.D.

Publications

A selection of recent and significant publications can be viewed below.

Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
Szymanski JM, Waldman M, Conry-Cantilena C, West KA.
J Clin Apher (2019 Aug) 34:495-498. Abstract/Full Text
Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.
Hasni S, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Joyal E, Fike A, Manna Z, Auh S, Shi Y, Chan D, Carlucci P, Biehl A, Dema B, Charles N, Balow JE, Waldman M, Siegel RM, Kaplan MJ, Rivera J.
Arthritis Rheumatol (2019 Jul) 71:1135-1140. Abstract/Full Text
Health-related quality of life in glomerular disease.
Canetta PA, Troost JP, Mahoney S, Kogon AJ, Carlozzi N, Bartosh SM, Cai Y, Davis TK, Fernandez H, Fornoni A, Gbadegesin RA, Herreshoff E, Mahan JD, Nachman PH, Selewski DT, Sethna CB, Srivastava T, Tuttle KR, Wang CS, Falk RJ, Gharavi AG, Gillespie BW, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Guay-Woodford LM, Reeve B, Gipson DS, CureGN Consortium..
Kidney Int (2019 May) 95:1209-1224. Abstract/Full Text
Effects of metreleptin on proteinuria in patients with lipodystrophy.
Lee HL, Waldman MA, Auh S, Balow JE, Cochran EK, Gorden P, Brown RJ.
J Clin Endocrinol Metab (2019 Apr 16) Abstract/Full Text
Autoantibodies are present before the clinical diagnosis of systemic sclerosis.
Burbelo PD, Gordon SM, Waldman M, Edison JD, Little DJ, Stitt RS, Bailey WT, Hughes JB, Olson SW.
PLoS One (2019) 14:e0214202. Abstract/Full Text
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM, CureGN Consortium..
Am J Kidney Dis (2019 Feb) 73:218-229. Abstract/Full Text
Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?
Mastellos DC, Reis ES, Biglarnia AR, Waldman M, Quigg RJ, Huber-Lang M, Seelen MA, Daha MR, Lambris JD.
Clin Immunol (2019 Jan) 198:102-105. Abstract/Full Text
Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center.
Waldman M, Han JC, Reyes-Capo DP, Bryant J, Carson KA, Turkbey B, Choyke P, Naggert JK, Gahl WA, Marshall JD, Gunay-Aygun M.
Mol Genet Metab (2018 Sep) 125:181-191. Abstract/Full Text
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.
J Clin Invest (2018 Jul 2) 128:3041-3052. Abstract/Full Text
Does TSH Reliably Detect Hypothyroid Patients?
Ling C, Sun Q, Khang J, Felipa Lastarria M, Strong J, Stolze B, Yu X, Parikh TP, Waldman MA, Welsh K, Jonklaas J, Masika L, Soldin SJ.
Ann Thyroid Res (2018) 4:122-125. Abstract/Full Text
Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis.
Abadie ME, Strich JR, Kim T, Xie YL, Fennelly KP, Olivier KN, Waldman M, Arora K, Holland SM, Chen RY.
Eur Respir J (2017 Dec) 50. Abstract/Full Text
Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy.
Burbelo PD, Beck LH Jr, Waldman M.
J Immunol Methods (2017 May) 444:17-23. Abstract/Full Text
A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.
Carmona-Rivera C, Purmalek MM, Moore E, Waldman M, Walter PJ, Garraffo HM, Phillips KA, Preston KL, Graf J, Kaplan MJ, Grayson PC.
JCI Insight (2017 Feb 9) 2:e89780. Abstract/Full Text
Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.
Waldman M, Beck LH Jr, Braun M, Wilkins K, Balow JE, Austin HA 3rd.
Kidney Int Rep (2016 Jul) 1:73-84. Abstract/Full Text
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.
Kao L, Lam V, Waldman M, Glassock RJ, Zhu Q.
J Am Soc Nephrol (2015 Feb) 26:291-301. Abstract/Full Text
Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.
Tseng J, Citrin DE, Waldman M, White DE, Rosenberg SA, Yang JC.
Cancer (2014 May 1) 120:1426-32. Abstract/Full Text
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.
Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH, Somers MJ, Trachtman H, Waldman M.
Am J Kidney Dis (2013 Sep) 62:403-41. Abstract/Full Text
Treatment of idiopathic membranous nephropathy.
Waldman M, Austin HA 3rd.
J Am Soc Nephrol (2012 Oct) 23:1617-30. Abstract/Full Text
Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses.
Shao WH, Kuan AP, Wang C, Abraham V, Waldman MA, Vogelgesang A, Wittenburg G, Choudhury A, Tsao PY, Miwa T, Eisenberg RA, Cohen PL.
J Autoimmun (2010 Dec) 35:368-74. Abstract/Full Text
Controversies in the treatment of idiopathic membranous nephropathy.
Waldman M, Austin HA 3rd.
Nat Rev Nephrol (2009 Aug) 5:469-79. Abstract/Full Text
Viruses and kidney disease: beyond HIV.
Waldman M, Marshall V, Whitby D, Kopp JB.
Semin Nephrol (2008 Nov) 28:595-607. Abstract/Full Text
Parvovirus-B19-associated complications in renal transplant recipients.
Waldman M, Kopp JB.
Nat Clin Pract Nephrol (2007 Oct) 3:540-50. Abstract/Full Text
Parvovirus B19 and the kidney.
Waldman M, Kopp JB.
Clin J Am Soc Nephrol (2007 Jul) 2 Suppl 1:S47-56. Abstract/Full Text
Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
Clin J Am Soc Nephrol (2007 May) 2:445-53. Abstract/Full Text